The first infusion of an investigational drug that aims to delay or help to prevent the earliest memory loss due to Alzheimer’s disease took place in September at Butler Hospital in Providence, R.I., researchers announced.
A new study from a Penn researcher adds to evidence that a class of antidepressant drugs known as SSRIs may reduce production of a key protein found in the brains of people with Alzheimer’s disease. This is evidence, she said, that the drugs could someday be part of a cocktail used to prevent or delay this form of dementia.
“Risk factors point to an increased chance of developing the disease, and while some risk factors can’t be changed, there are others within your control, such as diet, exercise and sleep,” Boling says.
In our link for today, Boling breaks down five risk factors that people can look out for to reduce the risk of dementia.
Beyond the U.S. deaths caused directly by the novel coronavirus, more than 134,200 people have died of Alzheimer’s and other forms of dementia since March. That is 13,200 more U.S. deaths caused by dementia than expected compared with previous years, according to an analysis of federal data by The Washington Post.